Wim J. Adriaensen
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Spatial mapping of Ethiopian cutaneous leishmaniasis lesions reveals distinct tissue level immune programs.
Journal: Frontiers in immunology
Published: May 01, 2026
Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort.
Journal: PLoS neglected tropical diseases
Published: December 18, 2025
Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape.
Journal: Frontiers in immunology
Published: December 11, 2025
Breaking the deadlock in antigen discovery for Leishmania vaccines.
Journal: Trends in parasitology
Published: December 05, 2025
Corrigendum to "Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC" [Vaccine 62 (2025) 127537].
Journal: Vaccine
Published: September 18, 2025
From dogma to data: charting a path forward for clinico-immunological research in Ethiopian cutaneous leishmaniasis.
Journal: Infectious diseases of poverty
Published: September 18, 2025
High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study.
Journal: The Lancet. Microbe
Published: June 18, 2025
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study.
Journal: The Lancet. Infectious diseases
Published: May 25, 2025
Multi-drug tolerance in Leishmania persister-like cells.
Journal: Communications biology
Published: March 04, 2025
No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With Monkeypox Virus Clade IIb Infected Patients.
Journal: Journal of medical virology
Published: October 01, 2024
Last Updated: 09/26/2026